NCT05386433: Paxlovid in the Treatment of COVID-19 Patients With Uremia
- State
- State not given
- Phase
- Early Phase 1
- People
- 40 planned
- Started
- Jun 2022
- Primary completion
- Jul 2022
- Arms
- standard-of-care plus Paxlovid
- Results
- None posted
- 23 May 2022: Trial registered